Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Shilan Mozaffari, Shekoufeh Nikfar & Mohammad Abdollahi. (2014) The safety of novel drugs used to treat irritable bowel syndrome. Expert Opinion on Drug Safety 13:5, pages 625-638.
Read now
Read now
Articles from other publishers (29)
Vasantha K. Kumar. 2022. Handbook on Opium. Handbook on Opium
205
219
.
Hua Huang, Ping Zhao, Meijuan Xi, Fang Li & Lijiang Ji. (2021) Mechanism of QingHuaZhiXie Prescription Regulating TLR4-IECs Pathway in the Intervention of Diarrhea Predominant Irritable Bowel Syndrome. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-9.
Crossref
Crossref
Raghav Seth, Sumanth S. Kuppalli, Danielle Nadav, Grant Chen & Amitabh Gulati. (2021) Recent Advances in Peripheral Opioid Receptor Therapeutics. Current Pain and Headache Reports 25:7.
Crossref
Crossref
Tao Che & Bryan L. Roth. (2021) Structural Insights Accelerate the Discovery of Opioid Alternatives. Annual Review of Biochemistry 90:1, pages 739-761.
Crossref
Crossref
Vicente Martínez & Raquel Abalo. (2020) Peripherally acting opioid analgesics and peripherally-induced analgesia. Behavioural Pharmacology 31:2&3, pages 136-158.
Crossref
Crossref
Agata Szymaszkiewicz, Martin Storr, Jakub Fichna & Marta Zielinska. (2018) Enkephalinase inhibitors, potential therapeutics for the future treatment of diarrhea predominant functional gastrointestinal disorders. Neurogastroenterology & Motility 31:4, pages e13526.
Crossref
Crossref
Halina Machelska & Melih Ö. Celik. (2018) Advances in Achieving Opioid Analgesia Without Side Effects. Frontiers in Pharmacology 9.
Crossref
Crossref
Magnus Simrén & Jan Tack. (2018) New treatments and therapeutic targets for IBS and other functional bowel disorders. Nature Reviews Gastroenterology & Hepatology 15:10, pages 589-605.
Crossref
Crossref
Emanuele Sinagra, Gaetano Cristian Morreale, Ghazaleh Mohammadian, Giorgio Fusco, Valentina Guarnotta, Giovanni Tomasello, Francesco Cappello, Francesca Rossi, Georgios Amvrosiadis & Dario Raimondo. (2017) New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond. World Journal of Gastroenterology 23:36, pages 6593-6627.
Crossref
Crossref
G. E. Boeckxstaens & M. M. Wouters. (2017) Neuroimmune factors in functional gastrointestinal disorders: A focus on irritable bowel syndrome. Neurogastroenterology & Motility 29:6, pages e13007.
Crossref
Crossref
Andy Wolff, Revan Kumar Joshi, Jörgen Ekström, Doron Aframian, Anne Marie Lynge Pedersen, Gordon Proctor, Nagamani Narayana, Alessandro Villa, Ying Wai Sia, Ardita Aliko, Richard McGowan, Alexander Ross Kerr, Siri Beier Jensen, Arjan Vissink & Colin Dawes. (2016) A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI. Drugs in R&D 17:1, pages 1-28.
Crossref
Crossref
John Broad, Damien Maurel, Victor W. S. Kung, Gareth A. Hicks, Michael Schemann, Michael R. Barnes, Terrence P. Kenakin, Sébastien Granier & Gareth J. Sanger. (2016) Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design. Scientific Reports 6:1.
Crossref
Crossref
Amy E. Foxx-Orenstein. (2016) New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists. Therapeutic Advances in Gastroenterology 9:3, pages 354-375.
Crossref
Crossref
O. Yu. Grechko, A. A. Spasov & D. M. Shtareva. (2016) Opioid κ Receptors as a Molecular Target for the Creation of a New Generation of Analgesic Drugs. Pharmaceutical Chemistry Journal 50:1, pages 1-9.
Crossref
Crossref
Andreas Brust, Daniel E. Croker, Barbara Colless, Lotten Ragnarsson, Åsa Andersson, Kapil Jain, Sonia Garcia-Caraballo, Joel Castro, Stuart M Brierley, Paul F. Alewood & Richard J. Lewis. (2016) Conopeptide-Derived κ-Opioid Agonists (Conorphins): Potent, Selective, and Metabolic Stable Dynorphin A Mimetics with Antinociceptive Properties. Journal of Medicinal Chemistry 59:6, pages 2381-2395.
Crossref
Crossref
B. Y. De Winter, A. Deiteren & J. G. De Man. (2016) Novel nervous system mechanisms in visceral pain. Neurogastroenterology & Motility 28:3, pages 309-315.
Crossref
Crossref
Paula Mosińska, Marta Zielińska & Jakub Fichna. (2016) Expression and physiology of opioid receptors in the gastrointestinal tract. Current Opinion in Endocrinology, Diabetes & Obesity 23:1, pages 3-10.
Crossref
Crossref
Maïly Devilliers, Jérôme Busserolles & Alain Eschalier. (2015) Le canal potassique TREK-1 : une cible moléculaire d’intérêt pour le développement d’antalgiques efficaces et bien tolérés. Douleurs : Evaluation - Diagnostic - Traitement 16:4, pages 164-171.
Crossref
Crossref
Seyed Reza Abtahi & Parvin Zareian. (2015) Assessment of Consensus-Based Pharmacological Therapies in Irritable Bowel Syndrome. Journal of Archives in Military Medicine 3:3.
Crossref
Crossref
Elena Guerrieri, Jayapal Reddy Mallareddy, Géza Tóth, Helmut Schmidhammer & Mariana Spetea. (2014)
Synthesis and Pharmacological Evaluation of [
3
H]HS665, a Novel, Highly Selective Radioligand for the Kappa Opioid Receptor
. ACS Chemical Neuroscience 6:3, pages 456-463.
Crossref
Crossref
Pradip K. Sasmal, C. Vamsee Krishna, S. Sudheerkumar Adabala, M. Roshaiah, Khaji Abdul Rawoof, Emima Thadi, K. Pavan Sukumar, Srisailam Cheera, Chandrasekhar Abbineni, K.V.L. Narasimha Rao, A. Prasanthi, Kamal Nijhawan, Mahaboobi Jaleel, Lakshmi Ramachandran Iyer, T. Krishna Chaitanya, Nirbhay Kumar Tiwari, N. Lavanya Krishna, Vijay Potluri, Ish Khanna, Thomas M. Frimurer, Michael Lückmann, Øystein Rist, Lisbeth Elster & Thomas Högberg. (2015) Optimisation of in silico derived 2-aminobenzimidazole hits as unprecedented selective kappa opioid receptor agonists. Bioorganic & Medicinal Chemistry Letters 25:4, pages 887-892.
Crossref
Crossref
Marta Zielińska, Chunqiu Chen, Anna Mokrowiecka, Adam I Cygankiewicz, Piotr K Zakrzewski, Maciej Sałaga, Ewa Małecka-Panas, Piotr Wlaź, Wanda M Krajewska & Jakub Fichna. (2015) Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome. Journal of Pharmacy and Pharmacology 67:2, pages 244-254.
Crossref
Crossref
Patrick A. Hughes, Melissa Moretta, Amanda Lim, Dallas J. Grasby, Daniel Bird, Stuart M. Brierley, Tobias Liebregts, Birgit Adam, L. Ashley Blackshaw, Gerald Holtmann, Peter Bampton, Peter Hoffmann, Jane M. Andrews, Heddy Zola & Doreen Krumbiegel. (2014) Immune derived opioidergic inhibition of viscerosensory afferents is decreased in Irritable Bowel Syndrome patients. Brain, Behavior, and Immunity 42, pages 191-203.
Crossref
Crossref
Patrick A Hughes, Joel Castro, Andrea M Harrington, Nicole Isaacs, Melissa Moretta, Gareth A Hicks, David M Urso & Stuart M Brierley. (2014) Increased κ-opioid receptor expression and function during chronic visceral hypersensitivity. Gut 63:7, pages 1199-1200.
Crossref
Crossref
David E. Reed & L. Ashley Blackshaw. (2014) Inhibition of visceral nociceptors. Frontiers in Pharmacology 5.
Crossref
Crossref
Pedram Paragomi, Reza Rahimian, Mohammad Hossein Kazemi, Mohammad Hadi Gharedaghi, Amin Khalifeh-Soltani, Saeedeh Azary, Abbas Norouzi Javidan, Kamran Moradi, Stephen Sakuma & Ahmad Reza Dehpour. (2014) Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea-predominant irritable bowel syndrome: Role of nitric oxide. Clinical and Experimental Pharmacology and Physiology 41:2, pages 118-126.
Crossref
Crossref
Rachel M. McQuade, Joel C. Bornstein & Kulmira Nurgali. (2014) Anti-Colorectal Cancer Chemotherapy-Induced Diarrhoea: Current Treatments and Side-Effects. International Journal of Clinical Medicine 05:07, pages 393-406.
Crossref
Crossref
Gabriela Trevisan, Mateus F. Rossato, Cristiani I.B. Walker, Sara M. Oliveira, Fernanda Rosa, Raquel Tonello, Cássia R. Silva, Pablo Machado, Aline A. Boligon, Marcos A.P. Martins, Nilo Zanatta, Hélio G. Bonacorso, Margareth L. Athayde, Maribel A. Rubin, João B. Calixto & Juliano Ferreira. (2013) A novel, potent, oral active and safe antinociceptive pyrazole targeting kappa opioid receptors. Neuropharmacology 73, pages 261-273.
Crossref
Crossref
Bassil Hassan & Victor Ruiz-Velasco. (2013) The κ-Opioid Receptor Agonist U-50488 Blocks Ca2+ Channels in a Voltage- and G Protein–Independent Manner in Sensory Neurons. Regional Anesthesia and Pain Medicine 38:1, pages 21-27.
Crossref
Crossref